Skip to main content

previous disabled Page of 3
and
  1. Article

    Open Access

    Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD Studies

    The growing recognition of holistic patient care highlights the various factors sha** the quality of life of individuals with autoimmune and rheumatic diseases (AIRDs). Beyond the traditional disease measure...

    Esha Kadam, Mahnoor Javaid, Parikshit Sen, Sreoshy Saha in Rheumatology International (2024)

  2. No Access

    Article

    Therapeutische Antikörper in der Rheumatologie

    Mit Emil von Behrings Serumtherapie der Diphtherie wurden erstmals Antikörper therapeutisch eingesetzt. Über 100 Jahre später begann 1998 mit der Zulassung von Infliximab, eines gegen Tumor-Nekrose-Faktor‑α (T...

    Fredrik N. Albach, Gerd-Rüdiger Burmester in Zeitschrift für Rheumatologie (2024)

  3. Article

    Open Access

    Filgotinib Demonstrates Efficacy in Rheumatoid Arthritis Independent of Smoking Status: Post Hoc Analysis of Phase 3 Trials and Claims-Based Analysis

    To assess cigarette smoking’s effects on efficacy of the preferential Janus kinase (JAK) 1 inhibitor filgotinib and drug persistence in patients with rheumatoid arthritis (RA).

    Jeffrey R. Curtis, Paul Emery, Bryan Downie, Yan Zhong in Rheumatology and Therapy (2024)

  4. Article

    Open Access

    Digital health information on autoinflammatory diseases: a YouTube quality analysis

    Getting access to specialists for autoinflammatory diseases (AID) can be challenging. Therefore, an increasing number of patients and healthcare professionals are seeking information on AID via the Internet, u...

    Mareen Sasse, Sarah Ohrndorf, Andriko Palmowski in Rheumatology International (2023)

  5. Article

    Open Access

    Macrophage activation syndrome in a patient with adult-onset Still’s disease following first COVID-19 vaccination with BNT162b2

    Adult-onset Still’s disease (AOSD) is an autoinflammatory multi-systemic syndrome. Macrophage activation syndrome (MAS) is a potentially life-threatening complication of AOSD with a mortality rate of 10–20%. E...

    Frédéric Muench, Martin Krusche, Leif Erik Sander, Thomas Rose in BMC Rheumatology (2021)

  6. Article

    Was ist gesichert in der Therapie von autoinflammatorischen Fiebererkrankungen?

    In den letzten 20 Jahren hat die Aufklärung von monogenetisch verursachten periodischen Fiebererkrankungen zum eigenständigen Konzept der Autoinflammation geführt. In diese heterogene Gruppe werden inzwischen ...

    Anne Pankow, Eugen Feist, Ulrich Baumann, Martin Kirschstein in Der Internist (2021)

  7. Article

    Nachruf der Deutschen Gesellschaft für Rheumatologie auf Prof. Joachim R. Kalden

    Prof. Hendrik Schulze-Koops, Gerd‑Rüdiger Burmester in Zeitschrift für Rheumatologie (2021)

  8. Article

    Open Access

    Golimumab as the First-, Second-, or at Least Third-Line Biologic Agent in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis: Post Hoc Analysis of a Noninterventional Study in Germany

    While golimumab (GLM) has demonstrated efficacy in rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS) in several randomized clinical trials with biologic-naïve patients, obse...

    Klaus Krüger, Gerd Rüdiger Burmester, Siegfried Wassenberg in Rheumatology and Therapy (2020)

  9. Article

    Open Access

    Fluorescence optical imaging for treatment monitoring in patients with early and active rheumatoid arthritis in a 1-year follow-up period

    Fluorescence optical imaging (FOI) enables visualization of inflammation in the hands in rheumatic joint diseases with currently a lack of long-term follow-up studies.

    Anne-Marie Glimm, Lisa Ines Sprenger, Ida Kristin Haugen in Arthritis Research & Therapy (2019)

  10. No Access

    Article

    Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What’s the Difference?

    Interleukin-6 (IL-6) signaling is a critical target in inflammatory pathways. Today, tocilizumab (TCZ) and sarilumab (SAR), two IL-6 receptor-inhibiting monoclonal antibodies, are widely used in the treatment ...

    Ali Berkant Avci, Eugen Feist, Gerd Rüdiger Burmester in BioDrugs (2018)

  11. Article

    Open Access

    Hypogalactosylation of immunoglobulin G in rheumatoid arthritis: relationship to HLA-DRB1 shared epitope, anticitrullinated protein antibodies, rheumatoid factor, and correlation with inflammatory activity

    Galactosylation of immunoglobulin G (IgG) is reduced in rheumatoid arthritis (RA) and assumed to correlate with inflammation and altered humoral immunity. IgG hypogalactosylation also increases with age. To in...

    Christian Schwedler, Thomas Häupl, Ulrich Kalus in Arthritis Research & Therapy (2018)

  12. Article

    Open Access

    Fluorescence optical imaging in pediatric patients with inflammatory and non-inflammatory joint diseases: a comparative study with ultrasonography

    Valid detection of arthritis is essential in differential diagnosis of joint pain. Indocyanin green (ICG)-enhanced fluorescence optical imaging (FOI) is a new imaging method that visualizes inflammation in wri...

    Marisa Christin Beck, Anne-Marie Glimm, Sarah Ohrndorf in Arthritis Research & Therapy (2017)

  13. No Access

    Article

    Type I interferon as a biomarker in autoimmunity and viral infection: a leukocyte subset-specific analysis unveils hidden diagnostic options

    Interferon alpha and its surrogates, including IP-10 and SIGLEC1, paralleled changes of disease activity in systemic lupus erythematosus (SLE). However, the whole blood interferon signature (WBIFNS)—the curren...

    Romy Strauß, Thomas Rose, Shaun M. Flint, Jens Klotsche in Journal of Molecular Medicine (2017)

  14. Article

    Open Access

    Disturbed microcirculation in the hands of patients with systemic sclerosis detected by fluorescence optical imaging: a pilot study

    Utilising fluorescence optical imaging (FOI), the distribution of an intravenously applied colouring agent indocyanine green (ICG) can be analysed with the potential to identify malperfusion by little to no ti...

    Stefanie Friedrich, Susanne Lüders in Arthritis Research & Therapy (2017)

  15. Article

    Open Access

    Sequential high-content profiling of the IgG-autoantibody repertoire reveals novel antigens in rheumatoid arthritis

    The aim was to identify novel diagnostic autoantibody candidates for rheumatoid arthritis (RA) by comprehensive screening for autoreactivity.

    Stefan Vordenbäumen, Angelika Lueking, Petra Budde in Arthritis Research & Therapy (2016)

  16. No Access

    Article

    A phase II investigator-initiated pilot study with low-dose cyclosporine A for the treatment of articular involvement in primary Sjögren’s syndrome

    This study aims to investigate the efficacy and safety of low-dose cyclosporine A (CyA) in patients with primary Sjögren’s syndrome (pSS) and articular involvement. This phase II open-label clinical study incl...

    Claudia Kedor, Jan Zernicke, Anja Hagemann, Lorena Martinez Gamboa in Clinical Rheumatology (2016)

  17. Article

    Open Access

    A prospective pilot study to evaluate an animated home-based physical exercise program as a treatment option for patients with rheumatoid arthritis

    Physical exercises and physiotherapy are of great importance for maintenance of joint function in patients with rheumatoid arthritis (RA). However, many RA patients complain about problems to receive prescript...

    Jan Zernicke, Claudia Kedor, Angela Müller in BMC Musculoskeletal Disorders (2016)

  18. No Access

    Article

    Disentangling the effects of tocilizumab on neutrophil survival and function

    The synovial tissue in rheumatoid arthritis (RA) represents a hypoxic environment with up-regulated pro-inflammatory cytokines and cellular infiltrates including neutrophils. Although inhibition of the interle...

    Timo Gaber, Martin Hahne, Cindy Strehl, Paula Hoff, Yvonne Dörffel in Immunologic Research (2016)

  19. Article

    Open Access

    Carbamylated vimentin represents a relevant autoantigen in Latin American (Cuban) rheumatoid arthritis patients

    Smoking produces substances that activate proinflammatory, prothrombotic and vasoconstrictive mediators via posttranslational carbamylation of proteins. As a new consequence of carbamylation, induction of anti...

    Goitybell Martínez, Jorge A. Gómez, Holger Bang in Rheumatology International (2016)

  20. No Access

    Article

    Effects of 60-day bed rest with and without exercise on cellular and humoral immunological parameters

    Exercise at regular intervals is assumed to have a positive effect on immune functions. Conversely, after spaceflight and under simulated weightlessness (e.g., bed rest), immune functions can be suppressed. We...

    Paula Hoff, Daniel L Belavý, Dörte Huscher in Cellular & Molecular Immunology (2015)

previous disabled Page of 3